Opioid Antagonist in the Treatment of Ischemic Stroke (Abstract)

Opioid Antagonist in the Treatment of Ischemic Stroke Brain Sci June 2021 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233760/ Stroke is a leading cause of death and disability, and novel treatments need to be found, particularly drugs with neuroprotective and restorative effects. Lately, there has been an increased interest in the relationship between opioids and ischemic stroke. To further appreciate this […]

Cathy – England: Tumefactive Multiple Sclerosis (TMS) (LDN, low dose naltrexone)

Cathy – England: Tumefactive Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo. Linda Elsegood: I’d like to introduce Kathy from England who takes LDN for TMS, which is tumefactive multiple sclerosis. Thank you for joining me, Kathy. Cathy: Thank you. Linda Elsegood: Could you tell us a bit about tumefactive […]

Opioid antagonists as potential therapeutics for ischemic stroke (Abstract)

Opioid antagonists as potential therapeutics for ischemic stroke Prog Neurobiol November 2009 https://pubmed.ncbi.nlm.nih.gov/31398359/# Chronic use of prescription opioids exacerbates risk and severity of ischemic stroke. Annually, 6 million people die from stroke worldwide and there are no neuroprotective or neurorestorative agents to improve stroke outcomes and promote recovery. Prescribed opioids such as morphine have been […]